EUVIMEDEUVIMED entdecken
Crossref

Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis

Shingo Konno iD, Toshiki Fujioka

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Shingo Konno und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Myasthenia Gravis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of the study was to investigate the serological factors in predicting symptom improvement in myasthenia gravis (MG) patients who underwent plasmapheresis (PP).

Methods

The relationship between symptom improvement and change in immunoglobin G (IgG) and acetylcholine receptor antibody (AchR‐Ab) levels in 21 MG patients after PP was analyzed.

Results

Patients were divided into two groups: the favorable ( n = 11) or unfavorable ( n = 10) response groups around the median MG composite improvement rate (50 [29, 56]%) 2 weeks after a PP course. In all patients, the IgG reduction rate before and after PP was higher in the favorable than the unfavorable response group. In AChR‐Ab‐positive patients, IgG and AChR‐Ab reduction rates were higher in the favorable than the unfavorable response group.

Conclusion

IgG reduction rate is a predictor of symptom improvement in MG patients who underwent PP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisHumansReceptors, CholinergicPlasmapheresisAutoantibodiesImmunoglobulin G

Stichwörter der Autor:innen

immunoglobin Gmyasthenia gravisplasmapheresispredictive factorprognosis

Substanzen

Receptors, CholinergicAutoantibodiesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan.

ORCID-Profile: Shingo Konno

Zitieren

APA

Konno, S., & Fujioka, T. (2024). Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14065

Vancouver

Konno S, Fujioka T. Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14065

BibTeX
@article{Konno2024,
  author = {Konno, Shingo and Fujioka, Toshiki},
  title = {Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14065}
}
Kostenlos starten →